Acording to a survey conducted in late 2023 and early 2024, some 73 percent of European countries who reported experiencing medicine shortages in their countries during the last 12 months reported increased co-payments as an adverse impact. This graph shows the adverse impacts of medicine shortages on patients in European countries who reported medicine shortages.
Adverse impacts of medicine shortages on patients in European countries who reported medicine shortages as of 2023
Original question: "In your experience, how have medicine shortages adversely affected patients in your country? Tick all that apply."
PGEU member countries who participated in the survey include Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden.
Medicine shortage was defined as every (temporary) inability for a community or hospital pharmacy to supply patients with the medicinal product requested as a result of factors beyond their control, requiring the dispensing of an alternative agent or even discontinuation of an ongoing medical therapy.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PGEU. (January 31, 2024). Adverse impacts of medicine shortages on patients in European countries who reported medicine shortages as of 2023 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1331206/european-countries-medicine-shortages-impact-on-patients/
PGEU. "Adverse impacts of medicine shortages on patients in European countries who reported medicine shortages as of 2023." Chart. January 31, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1331206/european-countries-medicine-shortages-impact-on-patients/
PGEU. (2024). Adverse impacts of medicine shortages on patients in European countries who reported medicine shortages as of 2023. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1331206/european-countries-medicine-shortages-impact-on-patients/
PGEU. "Adverse Impacts of Medicine Shortages on Patients in European Countries Who Reported Medicine Shortages as of 2023." Statista, Statista Inc., 31 Jan 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1331206/european-countries-medicine-shortages-impact-on-patients/
PGEU, Adverse impacts of medicine shortages on patients in European countries who reported medicine shortages as of 2023 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1331206/european-countries-medicine-shortages-impact-on-patients/ (last visited November 10, 2024)
Adverse impacts of medicine shortages on patients in European countries who reported medicine shortages as of 2023 [Graph], PGEU, January 31, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1331206/european-countries-medicine-shortages-impact-on-patients/
